{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Recherche pharmaceutique : Questions médicales les plus fréquentes",
"headline": "Recherche pharmaceutique : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Recherche pharmaceutique : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-05-10",
"dateModified": "2025-05-05",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Recherche pharmaceutique"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Recherche biomédicale",
"url": "https://questionsmedicales.fr/mesh/D035843",
"about": {
"@type": "MedicalCondition",
"name": "Recherche biomédicale",
"code": {
"@type": "MedicalCode",
"code": "D035843",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "H01.770.644.145"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Recherche pharmaceutique",
"alternateName": "Pharmaceutical Research",
"code": {
"@type": "MedicalCode",
"code": "D000071220",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Jun Yu",
"url": "https://questionsmedicales.fr/author/Jun%20Yu",
"affiliation": {
"@type": "Organization",
"name": "The Fourth Affiliated Hospital, Anhui Medical University, Hefei, Anhui, China."
}
},
{
"@type": "Person",
"name": "É Ferrand",
"url": "https://questionsmedicales.fr/author/%C3%89%20Ferrand",
"affiliation": {
"@type": "Organization",
"name": "Unité de recherche en pratique pharmaceutique et département de pharmacie, centre hospitalier universitaire Sainte-Justine, 3175, chemin de la Côte Sainte-Catherine, H3T 1C5 Montréal, QC, Canada."
}
},
{
"@type": "Person",
"name": "J-F Bussières",
"url": "https://questionsmedicales.fr/author/J-F%20Bussi%C3%A8res",
"affiliation": {
"@type": "Organization",
"name": "Unité de recherche en pratique pharmaceutique et département de pharmacie, centre hospitalier universitaire Sainte-Justine, 3175, chemin de la Côte Sainte-Catherine, H3T 1C5 Montréal, QC, Canada; Faculté de pharmacie, université de Montréal, Montréal, QC, Canada. Electronic address: jean-francois.bussieres.hsj@ssss.gouv.qc.ca."
}
},
{
"@type": "Person",
"name": "Kazuo Takayama",
"url": "https://questionsmedicales.fr/author/Kazuo%20Takayama",
"affiliation": {
"@type": "Organization",
"name": "Laboratory of Biochemistry and Molecular Biology, Graduate School of Pharmaceutical Sciences, Osaka University."
}
},
{
"@type": "Person",
"name": "Hiroyuki Mizuguchi",
"url": "https://questionsmedicales.fr/author/Hiroyuki%20Mizuguchi",
"affiliation": {
"@type": "Organization",
"name": "Laboratory of Biochemistry and Molecular Biology, Graduate School of Pharmaceutical Sciences, Osaka University, Osaka 565-0871, Japan."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "The effect of child development on the components of the Frequency Following Response: Child development and the Frequency Following Response.",
"datePublished": "2022-09-01",
"url": "https://questionsmedicales.fr/article/36048883",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1371/journal.pone.0260739"
}
},
{
"@type": "ScholarlyArticle",
"name": "Teleological Perspectives in Child and Adolescent Development.",
"datePublished": "2023-06-19",
"url": "https://questionsmedicales.fr/article/37341671",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.jaac.2023.05.007"
}
},
{
"@type": "ScholarlyArticle",
"name": "Risk and resilience models in child development.",
"datePublished": "2024-07-09",
"url": "https://questionsmedicales.fr/article/39260902",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/bs.acdb.2024.06.005"
}
},
{
"@type": "ScholarlyArticle",
"name": "Trajectories of child growth, child development, and home child-rearing quality during the Covid pandemic in rural Nepal.",
"datePublished": "2022-11-24",
"url": "https://questionsmedicales.fr/article/36355606",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1111/cch.13078"
}
},
{
"@type": "ScholarlyArticle",
"name": "Effect of parenting intervention through \"Care for Child Development Guideline\" on early child development and behaviors: a randomized controlled trial.",
"datePublished": "2022-12-02",
"url": "https://questionsmedicales.fr/article/36461019",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12887-022-03752-x"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Disciplines des sciences naturelles",
"item": "https://questionsmedicales.fr/mesh/D010811"
},
{
"@type": "ListItem",
"position": 3,
"name": "Science",
"item": "https://questionsmedicales.fr/mesh/D012586"
},
{
"@type": "ListItem",
"position": 4,
"name": "Recherche",
"item": "https://questionsmedicales.fr/mesh/D012106"
},
{
"@type": "ListItem",
"position": 5,
"name": "Recherche biomédicale",
"item": "https://questionsmedicales.fr/mesh/D035843"
},
{
"@type": "ListItem",
"position": 6,
"name": "Recherche pharmaceutique",
"item": "https://questionsmedicales.fr/mesh/D000071220"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Recherche pharmaceutique - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Recherche pharmaceutique",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-13",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Recherche pharmaceutique",
"description": "Comment évaluer l'efficacité d'un nouveau médicament ?\nQuels tests sont utilisés pour la recherche pharmaceutique ?\nComment identifier les effets secondaires d'un médicament ?\nQu'est-ce qu'une étude de phase I ?\nQuel rôle joue la biostatistique dans la recherche ?",
"url": "https://questionsmedicales.fr/mesh/D000071220?mesh_terms=Child+Development#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Recherche pharmaceutique",
"description": "Quels symptômes peuvent indiquer un effet secondaire ?\nComment les symptômes sont-ils surveillés en recherche ?\nLes symptômes varient-ils selon les populations ?\nComment les symptômes influencent-ils le développement d'un médicament ?\nQuels outils mesurent les symptômes en recherche ?",
"url": "https://questionsmedicales.fr/mesh/D000071220?mesh_terms=Child+Development#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Recherche pharmaceutique",
"description": "Comment prévenir les effets secondaires des médicaments ?\nQuelles stratégies sont utilisées pour la prévention ?\nComment la recherche aide-t-elle à prévenir les maladies ?\nQuel est le rôle des essais préventifs ?\nComment les recommandations de traitement aident-elles à la prévention ?",
"url": "https://questionsmedicales.fr/mesh/D000071220?mesh_terms=Child+Development#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Recherche pharmaceutique",
"description": "Comment un nouveau traitement est-il validé ?\nQuelles sont les étapes du développement d'un médicament ?\nComment les traitements sont-ils personnalisés ?\nQuel est le rôle des essais cliniques dans le traitement ?\nComment les traitements sont-ils évalués après commercialisation ?",
"url": "https://questionsmedicales.fr/mesh/D000071220?mesh_terms=Child+Development#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Recherche pharmaceutique",
"description": "Quelles complications peuvent survenir avec un nouveau médicament ?\nComment les complications sont-elles gérées en recherche ?\nQuel impact les complications ont-elles sur la recherche ?\nComment les données sur les complications sont-elles collectées ?\nLes complications influencent-elles l'approbation d'un médicament ?",
"url": "https://questionsmedicales.fr/mesh/D000071220?mesh_terms=Child+Development#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Recherche pharmaceutique",
"description": "Quels facteurs de risque sont étudiés en recherche pharmaceutique ?\nComment les facteurs de risque influencent-ils le développement des médicaments ?\nLes facteurs de risque sont-ils pris en compte dans les essais cliniques ?\nComment les facteurs de risque sont-ils évalués ?\nQuel rôle jouent les facteurs de risque dans la médecine personnalisée ?",
"url": "https://questionsmedicales.fr/mesh/D000071220?mesh_terms=Child+Development#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment évaluer l'efficacité d'un nouveau médicament ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'efficacité est évaluée par des essais cliniques contrôlés et des études comparatives."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour la recherche pharmaceutique ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests in vitro, in vivo et des études cliniques sont utilisés pour évaluer les médicaments."
}
},
{
"@type": "Question",
"name": "Comment identifier les effets secondaires d'un médicament ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les effets secondaires sont identifiés lors des essais cliniques et par la pharmacovigilance."
}
},
{
"@type": "Question",
"name": "Qu'est-ce qu'une étude de phase I ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une étude de phase I teste la sécurité et la tolérance d'un médicament sur un petit groupe."
}
},
{
"@type": "Question",
"name": "Quel rôle joue la biostatistique dans la recherche ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "La biostatistique analyse les données des essais cliniques pour évaluer l'efficacité et la sécurité."
}
},
{
"@type": "Question",
"name": "Quels symptômes peuvent indiquer un effet secondaire ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des nausées, des vertiges, des éruptions cutanées, etc."
}
},
{
"@type": "Question",
"name": "Comment les symptômes sont-ils surveillés en recherche ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes sont surveillés par des questionnaires et des évaluations cliniques régulières."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon les populations ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes peuvent varier en fonction de l'âge, du sexe et des comorbidités."
}
},
{
"@type": "Question",
"name": "Comment les symptômes influencent-ils le développement d'un médicament ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes guident la recherche sur les indications et les effets thérapeutiques des médicaments."
}
},
{
"@type": "Question",
"name": "Quels outils mesurent les symptômes en recherche ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des échelles d'évaluation, des questionnaires et des journaux de symptômes sont utilisés."
}
},
{
"@type": "Question",
"name": "Comment prévenir les effets secondaires des médicaments ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prévention inclut une évaluation rigoureuse des risques et une surveillance continue."
}
},
{
"@type": "Question",
"name": "Quelles stratégies sont utilisées pour la prévention ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des stratégies incluent l'éducation des patients et l'optimisation des posologies."
}
},
{
"@type": "Question",
"name": "Comment la recherche aide-t-elle à prévenir les maladies ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "La recherche identifie des cibles thérapeutiques et développe des vaccins et traitements préventifs."
}
},
{
"@type": "Question",
"name": "Quel est le rôle des essais préventifs ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les essais préventifs évaluent l'efficacité des interventions pour réduire le risque de maladies."
}
},
{
"@type": "Question",
"name": "Comment les recommandations de traitement aident-elles à la prévention ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les recommandations guident les professionnels de santé dans la prescription sécurisée des médicaments."
}
},
{
"@type": "Question",
"name": "Comment un nouveau traitement est-il validé ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un traitement est validé par des essais cliniques montrant son efficacité et sa sécurité."
}
},
{
"@type": "Question",
"name": "Quelles sont les étapes du développement d'un médicament ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les étapes incluent la découverte, le développement préclinique, et les essais cliniques."
}
},
{
"@type": "Question",
"name": "Comment les traitements sont-ils personnalisés ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements sont personnalisés en fonction des caractéristiques génétiques et cliniques des patients."
}
},
{
"@type": "Question",
"name": "Quel est le rôle des essais cliniques dans le traitement ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les essais cliniques testent l'efficacité et la sécurité des traitements avant leur approbation."
}
},
{
"@type": "Question",
"name": "Comment les traitements sont-ils évalués après commercialisation ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements sont évalués par la pharmacovigilance et des études post-commercialisation."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec un nouveau médicament ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des réactions allergiques, des interactions médicamenteuses, etc."
}
},
{
"@type": "Question",
"name": "Comment les complications sont-elles gérées en recherche ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications sont gérées par des protocoles de sécurité et des interventions médicales appropriées."
}
},
{
"@type": "Question",
"name": "Quel impact les complications ont-elles sur la recherche ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications peuvent retarder le développement et nécessiter des ajustements dans les essais."
}
},
{
"@type": "Question",
"name": "Comment les données sur les complications sont-elles collectées ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les données sont collectées par des rapports d'événements indésirables et des études de suivi."
}
},
{
"@type": "Question",
"name": "Les complications influencent-elles l'approbation d'un médicament ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les complications peuvent influencer l'approbation en affectant le rapport bénéfice-risque."
}
},
{
"@type": "Question",
"name": "Quels facteurs de risque sont étudiés en recherche pharmaceutique ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs de risque incluent l'âge, le sexe, les antécédents médicaux et les habitudes de vie."
}
},
{
"@type": "Question",
"name": "Comment les facteurs de risque influencent-ils le développement des médicaments ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils influencent la sélection des populations cibles et les stratégies de traitement."
}
},
{
"@type": "Question",
"name": "Les facteurs de risque sont-ils pris en compte dans les essais cliniques ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les essais cliniques stratifient souvent les participants selon les facteurs de risque."
}
},
{
"@type": "Question",
"name": "Comment les facteurs de risque sont-ils évalués ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils sont évalués par des questionnaires, des examens médicaux et des antécédents familiaux."
}
},
{
"@type": "Question",
"name": "Quel rôle jouent les facteurs de risque dans la médecine personnalisée ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils aident à adapter les traitements en fonction des caractéristiques individuelles des patients."
}
}
]
}
]
}
Unité de recherche en pratique pharmaceutique et département de pharmacie, centre hospitalier universitaire Sainte-Justine, 3175, chemin de la Côte Sainte-Catherine, H3T 1C5 Montréal, QC, Canada.
Unité de recherche en pratique pharmaceutique et département de pharmacie, centre hospitalier universitaire Sainte-Justine, 3175, chemin de la Côte Sainte-Catherine, H3T 1C5 Montréal, QC, Canada; Faculté de pharmacie, université de Montréal, Montréal, QC, Canada. Electronic address: jean-francois.bussieres.hsj@ssss.gouv.qc.ca.
Laboratory of Biochemistry and Molecular Biology, Graduate School of Pharmaceutical Sciences, Osaka University, Osaka 565-0871, Japan.
Laboratory of Hepatocyte Regulation, National Institutes of Biomedical Innovation, Health and Nutrition, Osaka 567-0085, Japan.
Global Center for Medical Engineering and Informatics, Osaka University, Osaka 565-0871, Japan.
Integrated Frontier Research for Medical Science Division, Institute for Open and Transdisciplinary Research Initiatives, Osaka University Osaka 565-0871, Japan.
Gastroenterology and Liver Diseases Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Key Laboratory of Drug-Targeting and Drug Delivery System of the Ministry of Education, West China School of Pharmacy, Sichuan University, Chengdu 610041, China.
National Laser Centre, Council for Scientific and Industrial Research, P.O. Box 395, Pretoria 0001, South Africa.
College of Agriculture, Engineering and Science, School of Chemistry and Physics, University of Kwa-Zulu Natal, University Road, Westville, Durban 3630, South Africa.
National Laser Centre, Council for Scientific and Industrial Research, P.O. Box 395, Pretoria 0001, South Africa.
College of Agriculture, Engineering and Science, School of Chemistry and Physics, University of Kwa-Zulu Natal, University Road, Westville, Durban 3630, South Africa.
During childhood, neuronal modifications occur so that typical childhood communicative development occurs. This work aims to contribute to the understanding of differences in the speech encoding of in...
The way adults think about children is of enormous consequence. Around the world, adults are "in charge" of children, claiming responsibility for their safety and lives. This may seem natural and intu...
This chapter provides the most comprehensive review of risk and resilience models for child development thus far, synthesizing these interdisciplinary frameworks for ease of use in research and practi...
Children, especially disadvantaged children in poor countries, were expected to be among the "biggest victims" of the Covid pandemic. Economic burdens, decreased nutritious foods, reduced medical care...
A planned nutrition intervention could not be implemented due to Covid restrictions. However, three surveys (pre-Covid [December 2019], July 2021, and September 2021) in 280 Nepali households (309 par...
Height, mid-upper-arm circumference, and head circumference measurements improved over time. The total ASQ-3 score did not change: Communication scores increased while fine motor and personal-social s...
In this sample, some aspects of child growth, development, and home child-rearing quality improved while others declined. Better understanding of these changes in child well-being and the family envir...
Several studies showed that parenting intervention programs play a core component in early child development. Considering the limited healthcare resources in developing countries, group-session interv...
This randomized controlled trial was conducted at an outpatient public Pediatrics clinic in Isfahan, Iran. We included 210 pregnant women aged 18-45 years in their third trimester and followed their c...
Overall, data of 181 children were included in the current study, including 80 in the intervention group and 101 controls. The adjusted median/mean differences between intervention and control groups ...
In this study, parenting interventions through CCD group sessions were significantly effective on just one subscale of children's socio-emotional behavior domains based on CBCL and one domain of child...
IRCT20190128042533N2, Date of registration: 16/01/2020, www.irct.ir....
Although infants in Neonatal Intensive Care Units (NICU) are at risk for developmental impairments and parents are at risk for emotional distress, factors that explain outcomes remain unknown. Here, w...
Participants included 101 families at The Children's Hospital of Philadelphia Neonatal Follow-Up Program who had been discharged 1.5-2.5 years prior. We gathered data using validated assessments, stan...
Our structural equation model, informed by the Double ABC-X Model, captured the dynamic relationships among infant, parent, couple, and family factors. Infant medical severity, posttraumatic stress, c...
Interventions that target parental posttraumatic stress, couple dynamics, parental perception of time for themselves, and access to financial support could be key for improving NICU family outcomes....
Most children born to women with epilepsy (WWE) are normal, but have increased risks for malformations and poor neuropsychological outcomes. Antiseizure medications (ASMs) are among the most commonly ...
China's uneven development under the urban-rural dichotomy has led to the discouraging development of children in rural areas. China is a large agricultural country and agricultural disasters are rela...
This study explored the effects of agricultural disasters on rural children's development, including cognitive and noncognitive skills, and academic pressure....
Survey data from the China Family Panel Survey and the National Meteorological Administration for 2010-2018 and a fixed-effect panel model with difference-in-differences regressions were used in the s...
The fixed effects model results showed evidence that agricultural disasters have a negative impact on rural children's cognitive and noncognitive skills and a positive impact on academic pressure. The...
Evidence shows that agricultural disasters have a significant negative impact on rural child development. It may be inferred that these will increase the difficulty of narrowing the urban-rural develo...
There is mixed evidence regarding the impact of interactive digital devices on child development. Tentatively some studies suggested that the use of digital devices may correlate negatively with langu...
To carry out this systematic review, databases CINAHL, MEDLINE, Embase, PsychINFO, Scopus and Google Scholar were searched for relevant studies....
We used the Joanna Briggs Institute methodology for systematic reviews....
Data extraction and synthesis was carried out by two reviewers and checked by a third reviewer. Studies were stratified into tiers depending on the level of evidence provided and the domain of develop...
Fifty-three studies were eligible for inclusion in the review, 39 Tier 1 (randomized controlled trials and quasi-experimental studies) and 16 Tier 2 (descriptive studies). Children's use of interactiv...
The studies included in this review were predominantly correlational or comparative in nature and focuses on cognitive domains of learning rather than a specific developmental outcome. It is difficult...
to comprehend men's perception of paternal parenthood while caring for infants to promote child development....
this qualitative study adopts an exploratory approach and was conducted with undergraduate and graduate students, faculty, and staff who are fathers of infants up to 6 months old from a higher educati...
fifteen men participated in the study. From the analysis, two empirical categories emerged: "Perception of being a father: challenges and novelties" and "Promotion of child development: actions carrie...
the relevance of the paternal figure for child development is highlighted, as well as the need for public policies to encourage paternal parenthood....